BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18588458)

  • 21. Intraperitoneal chemotherapy for ovarian carcinoma.
    Markman M
    Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive approach to advanced primary and recurrent ovarian cancer: a personal experience.
    Carmignani CP; Sugarbaker PH
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):477-87. PubMed ID: 15161446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.
    Meredith RF; Buchsbaum DJ; Alvarez RD; LoBuglio AF
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5643s-5645s. PubMed ID: 17875801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
    Myers CE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal chemotherapy in ovarian cancer.
    Hofstra LS; de Vries EG; Mulder NH; Willemse PH
    Cancer Treat Rev; 2000 Apr; 26(2):133-43. PubMed ID: 10772970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraperitoneal chemotherapy in ovarian cancer: an update.
    Runowicz CD
    Cancer J; 2008; 14(1):7-9. PubMed ID: 18303475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraperitoneal chemotherapy.
    Schneider JG
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):195-212. PubMed ID: 8015764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view.
    Vergote I; Amant F; Leunen K; Cadron I; Van Gorp T; Neven P; Berteloot P
    Oncologist; 2008 Apr; 13(4):410-4. PubMed ID: 18448555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer].
    Massard C; Lhommé C; Pautier P
    Bull Cancer; 2007 Apr; 94(4):398-404. PubMed ID: 17449443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Lan C; Li Y; Liu J
    Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.
    Hydzik C
    Clin J Oncol Nurs; 2007 Apr; 11(2):221-5. PubMed ID: 17573271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gynecologic cancer].
    Uehara T; Katsumata N
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1488-94. PubMed ID: 18799902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Petru E; Benedicic Ch; Huell A
    Gynecol Oncol; 2006 Jul; 102(1):129; author reply 130. PubMed ID: 16600354
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of women with newly diagnosed ovarian cancer.
    Krasner C; Duska L
    Semin Oncol; 2009 Apr; 36(2):91-105. PubMed ID: 19332244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal Therapy of Ovarian Cancer.
    Markman M
    Oncologist; 1996; 1(1 & 2):18-21. PubMed ID: 10387964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The port: delivering intraperitoneal chemotherapy in ovarian cancer.
    Doane LS
    Todays OR Nurse; 1992 Sep; 14(9):11-8. PubMed ID: 1412628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-line systemic treatment of ovarian cancer: a critical review of available evidence and expectations for future directions.
    Metzger-Filho O; Moulin C; D'Hondt V
    Curr Opin Oncol; 2010 Sep; 22(5):513-20. PubMed ID: 20485166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer.
    Fujiwara K; Nagao S; Aotani E; Hasegawa K
    Expert Opin Pharmacother; 2013 Sep; 14(13):1797-806. PubMed ID: 23915009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACOG Committee Opinion No. 396. Intraperitoneal chemotherapy for ovarian cancer.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2008 Jan; 111(1):249. PubMed ID: 18165421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.